aTyr Pharma, Inc.
ATYRBiotechnology
$5.37+4.56%As of Oct 29vs prior close
- P/E (TTM)
- –
- From 52W high
- −87.21%
- EPS (LTM)
- -$0.80
- Revenue (LTM)
- $190K
- Net margin
- -39009.47%
- Dividend yield
- 0.00%
Nomior Score
8
Fragile PremiumBottom 2% of the scored universe
Growth46
Quality16
Value33
Momentum12
Resilience27
Growth
−12.45%revenue a year over 6 fiscal years
YE19 $422KLTM $190K
Connections
Revenue to profitQ3 YE25
The operating loss was 14076% of revenue.
Who owns it
1fund